Premier Late-Stage Healthcare Private Equity Investors

Bridge Point Private Equity (Bridge Point) is a cross-border private equity fund dedicated to actively pursuing primarily late stage U.S Healthcare companies that will benefit from penetrating the vast Chinese Healthcare market. We identify the well-managed western companies with advanced technology or systems to disrupt the global healthcare market, especially the ones with great market potential in China.

HEALTHCARE-FOCUSED INVESTMENT STRATEGY

Bridge Point will leverage our cross-border expertise, vast network of strategic industry contacts, and deep knowledge of the healthcare industry to achieve compelling risk-adjusted returns for our investors. The fund has identified a handful of attractive sub-sectors that we believe are best-positioned to capture the rapid growth and transformation of both the Chinese and U.S healthcare markets.

Medical Services

• Private Hospitals
• Online Consultation & Treatment
• Rehabilitation Treatment

Pharmaceuticals & Other Regulated Products

• Diagnostic Devices
• Intelligent Wearables
• Niche Medicine

Support Services

• Hospital Management
• Pharmaceutical Logistics
• Big Data/AI Patient Data Management

VALUE CREATION STRATEGY